{"name":"Eirion Therapeutics Inc.","slug":"eirion-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AI-09","genericName":"AI-09","slug":"ai-09","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AI-09","genericName":"AI-09","slug":"ai-09","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQY2Z3UnQ5ZHJJUmgwbUtDZnJJWUNjREVUVVBsSEk0eTd0aWRUUW8wOFBGT183d3doT2dsSGxzOU9ZT2VSWWdYZktiZ05LN285MDZJb1gya0lKZzZhUmJORndUWWt4TVBWRl9ER3VTVldKUXJ3c3U0ZjV3QUV0OERzRmV4SmZNbGU5WWU4eklfWnNHTWowdkUtNlRFVUNWTnNwMzFHeGxuMG55dUpGRjg4dmhXU2R2U0RvSDVCSzlYODFPNmN5Z1NlWkw0WVA5RmNHVEVtcURwbXlDWmRaTG44N0ZnZ2tMOF96RlZKYWRR?oc=5","date":"2025-07-09","type":"pipeline","source":"prnewswire.com","summary":"Eirion Therapeutics to Present at the 2025 American Academy of Dermatology Innovation Academy Meeting - prnewswire.com","headline":"Eirion Therapeutics to Present at the 2025 American Academy of Dermatology Innovation Academy Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE82c3J6VGUwOEZKcmtXU1lHaF9GUTBBekE3OU1pQVFQaHpJbzZxRHBSVXNuRkJ6SDNuWC1BOTN5V0tjdTl4aHlFRFpuS1kyRG1nVVhQbXlTTzQtZS04OHlrSg?oc=5","date":"2025-03-13","type":"pipeline","source":"Straits Research","summary":"Minoxidil Market Size, Global Trends, Growth & Insights by 2033 - Straits Research","headline":"Minoxidil Market Size, Global Trends, Growth & Insights by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNcGRaLUFTRTAxUlNYdnVEcG13cmFnVnlnR0dEY0ZvSmxBX1gxbTJRamhHekpMa0EyOTVmNEY3cjBoTFlXcFFoSGpQQkdHZTBEUFM2NGdGSFEwX0EtR3o5TENtRlVYai0zeWk3NTlsQnlKVGhBYUhtOTdBbnlwS1BRMm5aTjFGTThhd0RjQzBVQjJPdV92b2Q5Vnl2X2NhZW95RDhhQ09TUWpGaG1fV1VKbVJFTnF4OVktUWdMRmJIa1BTQ3M?oc=5","date":"2025-01-09","type":"trial","source":"Dermatology Times","summary":"ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment - Dermatology Times","headline":"ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQN0V5cndFMDd0bG85ZTJsZGs2SXBreEpJaHVfY0JjZU1oVURqMFhaaG95aDJNbGhndnZYa3pGOUNBX1RCOXB0SEhpNDl2VU45NVB2ck1nbDA1aGpfdE9vN2xhcXdnVTJRV2FwLVNZaERlUVRPYVZoeng0SHNOc3VnVnV3Y0tjNzE4MVgtX3g1RWN2Ymtpb2hncDBWX2hZeFR1cFlsSnZzZVE0c0VUUXJ1QzRwNFRCSDAxRDNGR0MyVXk2czlnMXM4VHRPNG0wT0xTLU5BMWNRWkdJcmlyVHdtMXoyZC1sZmhGZGZoVGVUZjlPS0dNWmtZcWJTeFBmVlFwYjNCbzVadnU?oc=5","date":"2025-01-08","type":"trial","source":"prnewswire.com","summary":"Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results - prnewswire.com","headline":"Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Result","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxORjAtRFB4NDdiRVdyRVhfTVVjQkc5c1dQWWpDeWhKWkFqUDktcjQtakpWWnZBN1pmek1oUUpRZzhqWlJFdDJDczdzMWRHV3VEOFl3Sk9rZUNIWWJwUllPYUtKVmxEZjN4bzFUYldMdUhsZHdxS2pXR2VoZGhqMjJjUXpnTldUbEF2M2dfYnI4YUMxODV1aHduNGY4b0Ffdk9XZ19naEdYaE9lanZnX2c?oc=5","date":"2025-01-08","type":"trial","source":"Clinical Trials Arena","summary":"Eirion sees success in ‘first-in-man’ topical hair-loss therapy trial - Clinical Trials Arena","headline":"Eirion sees success in ‘first-in-man’ topical hair-loss therapy trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOU3lJVUxKQ2szRFBsdHkzSTNyaDJJeUFwU3lFQUFsUnl6MzN0VFp3VTFoR2d6SHJBT0FLUDdieEdGNEl5NWdSaHowYlh1NXFhLTJkZkJxSVRaeGplVU9xVm8xb0QtOGJJN0lGSzlmQTRzSENKWTRlQ3RodHZ4UzR0N3A3QVpldk1aRHVicDBOYTZVeVZFYVRmNXJOcXUtVDVIZXJDUURBNmY1SWpXWTVyTEtvUDBDeTVBak5na1lWSk94TDkzVlEwQlRUMjlnLWVhWWZmZmJobnhrVU5xZU5kdks2WWNiYVZZeDB2VzZNQ25uRjRmWUlF?oc=5","date":"2024-07-01","type":"trial","source":"BioSpace","summary":"Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Topical ET-02 for the Treatment of Androgenic Alopecia - BioSpace","headline":"Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Topical ET-02 for the Treatment of ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOdW5XcVhlM1JtZWpFbF9vWkpWM3R4WTJ3WXpGWmE3NWpHd1lmbmhvV0hCY2E4c053eFhEaEIwQzN5dHdrdjFhZkVHaWpQRmhMWl9PYnJuTFQ5eFNmLXZDZVYzOU15NTl0dG43Q3ZkSi1BTjItWDhnZmItbUxSSnJZNDc0OVhkWnVnTkxHRWd5MVluVVdKRl94amVkb3FjUTliQnE0NEJHZXV1anh2eWlZa3J6UmlabG51N1prbURfdTJSZHdBZzhLSUFPNmtaaDd1UjZERU1sRmZtRlBwU2doVWViTVYtQThGcjhmdlJFQ09sV2dONHBvOGtUb1FmVGFRaDRLZll0WFZfUGs2QjRj?oc=5","date":"2021-09-08","type":"pipeline","source":"prnewswire.com","summary":"Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion's Exclusive Botulinum API Manufacturer - prnewswire.com","headline":"Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion's Exclusive Botulinum API Manuf","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNbnpRSy1tekF2bVE5bnVSSUlZLUVjMWd6WWk5ellEUDBWZmxCRDFrc19JSTh1TVRNdWZPU0ZiX0pWWGo1OVFTRXdES0YwdDNMOGR5ZXkwMGhObHFPSlViVDl3TjZnS1ZRN1VKMktLVXF0VmhyRnRneWd1TVdPQVZUMmdIbFYxcE1FZWlESVZ5QWU1NmdFYjVJQ2syVWc0Z1JBY0pBbjFyUGdQMlhuLVBFVnhJMkdyUW1hVEtPZ0d1RE1LOXZ1RGQ2Tk1zeTA1ZmU5Zmt2ZTQ5M05FSVFPYnh5N2dXOW16VERjTlo2ZHI1a3d6Sy1vbzFkU2pESUl5emdicGo0ai1qTVFyWGJ3a2RZTw?oc=5","date":"2021-03-09","type":"deal","source":"prnewswire.com","summary":"Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd. - prnewswire.com","headline":"Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Tech","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}